{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T21:29:18Z","timestamp":1777152558027,"version":"3.51.4"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100009053","name":"DBT\/Wellcome Trust India Alliance","doi-asserted-by":"publisher","award":["WTA\/24\/006"],"award-info":[{"award-number":["WTA\/24\/006"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Malaria vaccines are crucial for advancing public health and achieving malaria elimination. Currently, pre-erythrocytic vaccines like RTS, S\/AS01 and R21\/Matrix-M are in use, but their effectiveness is limited. Ongoing research on blood-stage vaccine candidates such as RH5, MSP1 and MSP3 has shown promising results. Incorporating a blood-stage vaccine could greatly enhance malaria control by targeting the symptomatic phase of the infection, providing additional protection alongside pre-erythrocytic vaccines and other control methods. Understanding the structural biology and immunological interactions of blood-stage antigens is essential for developing effective vaccines. Combining pre-erythrocytic and erythrocytic-stage vaccines could lead to better protection, improved public health outcomes and significant progress toward malaria elimination.<\/jats:p>","DOI":"10.1093\/trstmh\/traf013","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T15:19:49Z","timestamp":1737472789000},"page":"1200-1203","source":"Crossref","is-referenced-by-count":3,"title":["Unlocking the potential of blood-stage vaccines for malaria elimination"],"prefix":"10.1093","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0296-8296","authenticated-orcid":false,"given":"Shrikant","family":"Nema","sequence":"first","affiliation":[{"name":"International Center for Genetic Engineering and Biotechnology (ICGEB) Malaria Biology Group, , Aruna Asaf Ali Marg, 110067 New Delhi ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Rathore","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Science (AIIMS) Department of Biotechnology, , Ansari Nagar, 110029 New Delhi ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Mohmmed","sequence":"additional","affiliation":[{"name":"International Center for Genetic Engineering and Biotechnology (ICGEB) Parasite Cell Biology Group, , Aruna Asaf Ali Marg, 110067 New Delhi ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan","family":"Malhotra","sequence":"additional","affiliation":[{"name":"International Center for Genetic Engineering and Biotechnology (ICGEB) Malaria Biology Group, , Aruna Asaf Ali Marg, 110067 New Delhi ,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"key":"2025100108461363700_bib1","author":"World Health Organization (WHO)","journal-title":"World Malaria Report 2023"},{"issue":"6","key":"2025100108461363700_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/1995-7645.378560","article-title":"R21 vaccine: a ray of hope for malaria elimination","volume":"16","author":"Nitika","year":"2023","journal-title":"Asian Pac J Trop Med"},{"issue":"3","key":"2025100108461363700_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1179\/136485910X12647085215534","article-title":"Blood-stage malaria vaccines\u2014recent progress and future challenges","volume":"104","author":"Goodman","year":"2010","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"2025100108461363700_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/14760584.2016.1141680","article-title":"Progress and prospects for blood-stage malaria vaccines","volume":"15","author":"Miura","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"2025100108461363700_bib5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S1473-3099(24)00312-8","article-title":"Blood-stage malaria vaccine candidate RH5.1\/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial","volume":"24","author":"Silk","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025100108461363700_bib6","volume-title":"A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21 [Internet]","author":"University of Oxford","year":"2023."},{"key":"2025100108461363700_bib7"},{"issue":"1","key":"2025100108461363700_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/14760584.2023.2295430","article-title":"Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate","volume":"23","author":"Thomson-Luque","year":"2024","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"2025100108461363700_bib9","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1172\/JCI44423","article-title":"Advances and challenges in malaria vaccine development","volume":"120","author":"Crompton","year":"2010","journal-title":"J Clin Invest"},{"issue":"704","key":"2025100108461363700_bib10","doi-asserted-by":"crossref","first-page":"eadf1782","DOI":"10.1126\/scitranslmed.adf1782","article-title":"Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection","volume":"15","author":"Hou","year":"2023","journal-title":"Sci Transl Med"},{"issue":"4","key":"2025100108461363700_bib11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/vaccines8040651","article-title":"Pullulan-coated iron oxide nanoparticles for blood-stage malaria vaccine delivery","volume":"8","author":"Powles","year":"2020","journal-title":"Vaccines"},{"issue":"10441","key":"2025100108461363700_bib12","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/S0140-6736(24)00850-X","article-title":"Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization","volume":"403","author":"Shattock","year":"2024","journal-title":"Lancet"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/119\/10\/1200\/61810797\/traf013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/119\/10\/1200\/61810797\/traf013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:46:21Z","timestamp":1759322781000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/119\/10\/1200\/8005550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":12,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,2,8]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/traf013","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,2,8]]}}}